Suzhou Zelgen Biopharmaceuticals Hits Day Low Amid Price Pressure at CNY 96.53

Suzhou Zelgen Biopharmaceuticals Co., Ltd. experienced a notable decline today, with the stock dropping by 3.95% on May 28, 2026. The stock reached an intraday low of CNY 96.53, reflecting ongoing challenges in its market performance. Over the past week, the stock has seen a decrease of 6.15%, and its one-month performance shows a decline of 2.64%. In the context of the broader market, the China Shanghai Composite index has performed positively, gaining 0.12% today and 0.52% over the past week. In contrast, Suzhou Zelgen's one-year performance remains negative at -2.66%, significantly underperforming the index, which has risen by 22.72% during the same period. Despite reporting positive results for the last four consecutive quarters, the company faces challenges such as a low return on capital employed and a negative net worth. The market capitalization stands at CNY 27,093 million, categorizing it as a large-cap company within the pharmaceuticals and biotechnology sector. Investors may want to monitor these trends closely as the company navigates its current financial landscape.